MARLY Stock Overview
Provides health services in Colombia. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Clínica de Marly S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | Col$8,500.00 |
52 Week High | Col$0 |
52 Week Low | Col$0 |
Beta | 0.013 |
1 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | 0% |
3 Year Change | 32.81% |
5 Year Change | 28.79% |
Change since IPO | 300.23% |
Recent News & Updates
Recent updates
Shareholder Returns
MARLY | CO Healthcare | CO Market | |
---|---|---|---|
7D | 0% | -10.3% | -1.5% |
1Y | 0% | -31.1% | 7.5% |
Return vs Industry: MARLY exceeded the CO Healthcare industry which returned -31.1% over the past year.
Return vs Market: MARLY underperformed the CO Market which returned 7.5% over the past year.
Price Volatility
MARLY volatility | |
---|---|
MARLY Average Weekly Movement | 0% |
Healthcare Industry Average Movement | 6.5% |
Market Average Movement | 3.3% |
10% most volatile stocks in CO Market | 8.0% |
10% least volatile stocks in CO Market | 1.8% |
Stable Share Price: Data is not available.
Volatility Over Time: Insufficient data to determine MARLY's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1903 | 833 | Luis Eduardo Castro | marly.com.co |
Clínica de Marly S.A. provides health services in Colombia. The company offers services in the areas of anesthesia, bronchoscopy, cardiology, bariatric surgery, column surgery, hand surgery, general surgery, maxillofacial surgery, plastic and reconstructive surgery, other surgery, pain clinic, coloproctology, palliative care, dermatology, endocrinology, physiatry, gastroenterology, gynecology, hematology, diagnostic imaging, infectology, and neurodiagnostic and pathology laboratory. It also provides vascular laboratory non-invasive method, internal medicine, nephrology, neonatology and pediatrics, pneumology, functional and restorative neurosurgery, neurology, ophthalmology, clinical oncology, orthopedics and traumatology, otorhinolaryngology, psychiatry, rheumatology, bone marrow transplant, intermediate and intensive care unit, outpatient chemotherapy, clinical laboratory, maternal fetal medicine unit, emergency, and urology, as well as digestive physiology laboratory services.
Clínica de Marly S.A. Fundamentals Summary
MARLY fundamental statistics | |
---|---|
Market cap | Col$90.76b |
Earnings (TTM) | Col$80.81b |
Revenue (TTM) | Col$399.60b |
1.1x
P/E Ratio0.2x
P/S RatioIs MARLY overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MARLY income statement (TTM) | |
---|---|
Revenue | Col$399.60b |
Cost of Revenue | Col$249.67b |
Gross Profit | Col$149.92b |
Other Expenses | Col$69.11b |
Earnings | Col$80.81b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 7.57k |
Gross Margin | 37.52% |
Net Profit Margin | 20.22% |
Debt/Equity Ratio | 0.8% |
How did MARLY perform over the long term?
See historical performance and comparisonDividends
15.4%
Current Dividend Yield20%
Payout RatioDoes MARLY pay a reliable dividends?
See MARLY dividend history and benchmarksClínica de Marly dividend dates | |
---|---|
Ex Dividend Date | Jan 06 2025 |
Dividend Pay Date | Jan 10 2025 |
Days until Ex dividend | 17 days |
Days until Dividend pay date | 21 days |
Does MARLY pay a reliable dividends?
See MARLY dividend history and benchmarksCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/19 12:18 |
End of Day Share Price | 2024/12/18 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Clínica de Marly S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|